Repeat dosing of rocuronium 1.2 mg kg−1 after reversal of neuromuscular block by sugammadex 4.0 mg kg−1 in anaesthetized healthy volunteers: a modelling-based pilot study
Authors:
Open Access
- 14 July 2010
- journal article
- clinical trial
- Published by Elsevier in British Journal of Anaesthesia
- Vol. 105 (4) , 487-492
Abstract
Re-intubation and re-operation may occasionally be required after neuromuscular block (NMB) reversal. This study evaluated block onset times of a second dose of rocuronium (1.2 mg kg−1) after sugammadex reversal of rocuronium 0.6 mg kg−1. In this open-label study of healthy anaesthetized volunteers, subjects received rocuronium 0.6 mg kg−1, were antagonized at 1–2 post-tetanic counts with sugammadex 4.0 mg kg−1, and received rocuronium 1.2 mg kg−1 at 5, 7.5, 10, 15, 20, 22.5, 25, 27.5, 30, 45, or 60 min after sugammadex. Spontaneous recovery occurred after repeat rocuronium dose. Primary endpoints were the onset time of maximal block (time to lowest T1 value reached) and the clinical duration of block (until T1=25%) after repeat rocuronium dose. Sixteen subjects were included. For subjects receiving rocuronium 1.2 mg kg−1 5 min after sugammadex (n=6), mean (sd) onset time (to T1=0) was 3.06 (0.97) min; range, 1.92–4.72 min. For repeat dose time points ≥25 min (n=5), mean onset was faster (1.73 min) than for repeat doses vs 38.2 min for repeat doses ≥25 min. Rapid re-onset of NMB occurred after repeat dose of rocuronium 1.2 mg kg−1 as early as 5 min after sugammadex in healthy volunteers. Re-onset of block took longer if second rocuronium dose was <25 min after sugammadex. The duration of action of second rocuronium dose increased with later repeat dose time points.Keywords
This publication has 13 references indexed in Scilit:
- Preclinical pharmacology of sugammadexJournal of Critical Care, 2009
- Reversal of Profound Rocuronium-induced Blockade with SugammadexAnesthesiology, 2008
- Early Reversal of Profound Rocuronium-induced Neuromuscular Blockade by Sugammadex in a Randomized Multicenter Study: Efficacy, Safety, and PharmacokineticsAnesthesiology, 2007
- Reversal of Rocuronium-Induced Neuromuscular Block with the Novel Drug Sugammadex Is Equally Effective Under Maintenance Anesthesia with Propofol or SevofluraneAnesthesia & Analgesia, 2007
- A Randomized, Dose-Finding, Phase II Study of the Selective Relaxant Binding Drug, Sugammadex, Capable of Safely Reversing Profound Rocuronium-Induced Neuromuscular BlockAnesthesia & Analgesia, 2007
- Sugammadex Reversal of Rocuronium-Induced Neuromuscular Blockade: A Comparison with Neostigmine???Glycopyrrolate and Edrophonium???AtropineAnesthesia & Analgesia, 2007
- Effective Reversal of Moderate Rocuronium- or Vecuronium-induced Neuromuscular Block with Sugammadex, a Selective Relaxant Binding AgentAnesthesiology, 2007
- Reversal of Rocuronium-induced Neuromuscular Block by the Selective Relaxant Binding Agent SugammadexAnesthesiology, 2006
- Org 25969 (sugammadex), a selective relaxant binding agent for antagonism of prolonged rocuronium-induced neuromuscular blockBritish Journal of Anaesthesia, 2005
- Determination of the Hemodynamics and Histamine Release of Rocuronium (Org 9426) When Administered in Increased Doses Under N[2]O/O[2]-Sufentanil AnesthesiaAnesthesia & Analgesia, 1994